About this journal

Aims and scope

Amyloid is the official journal of the International Society of Amyloidosis.

Amyloid publishes basic and clinical research on amyloids and systemic and localized amyloidosis.The journal's scope and major areas of focus are:

  • Etiology
  • Epidemiology
  • Genetics
  • Pathogenesis, including chemical structure, fibrillogenesis and mechanism of disease
  • Pathology
  • Diagnosis, treatment and prognosis across a broad spectrum of clinical specialties impacted by various amyloid diseases and related disorders.

The journal publishes research articles, letters to the Editor, review articles (typically by invitation), and editorials.

Authors can choose to publish gold open access in this journal.

Journal metrics

Usage

  • 125K annual downloads/views

Citation metrics

  • 5.2 (2023) Impact Factor
  • Q1 Impact Factor Best Quartile
  • 6.7 (2023) 5 year IF
  • 10.6 (2023) CiteScore (Scopus)
  • Q1 CiteScore Best Quartile
  • 1.939 (2023) SNIP
  • 2.007 (2023) SJR

Speed/acceptance

  • 20 days avg. from submission to first decision
  • 46 days avg. from submission to first post-review decision
  • 20% acceptance rate

Editorial board

Editor-in-Chief:
Prof Per Westermark - Uppsala University, Uppsala, Sweden

Associate Editors:
Angela Dispenzieri - Mayo Clinic, USA
Mathew S. Maurer - Columbia University, USA
Giampaolo Merlini - Amyloidosis Research and Treatment Center, Italy
Vaishali Sanchorawala - Boston University School of Medicine, USA
Stefan Schönland - University Hospital of Heidelberg, Germany
Yoshiki Sekijima - Shinshu University School of Medicine, Japan

Editorial Board:
David Adams - France
Kevin M. Alexander - USA
Intissar Anan - Sweden
Yukio Ando - Japan
Gunnar Antoni - Sweden
Vittorio Bellotti - Italy
John L. Berk - USA
Joel N. Buxbaum - USA
Fabrizio Chiti - Italy
Teresa Coelho - Portugal
Isabel Conceicao - Portugal
Thibaud Damy - France
Noel Dasgupta - USA
Sharmila Dorbala - USA
David S. Eisenberg - USA
Michele Emdin - Italy
Rodney H. Falk - USA
Marcus Fändrich - Germany
Pablo Garcia-Pavia - Spain
Ehud Gazit - Israel
Morie A. Gertz - USA
Justin L. Grodin - USA
Per Hammarström - Sweden
Philip N. Hawkins - UK
Bouke P.C. Hazenberg - Netherlands
Ute Hegenbart - Germany
Keiichi Higuchi - Japan
Arnaud Jaccard - France
Daniel P. Judge - USA
Astrid Juhl Terkelsen - Denmark
Aphrodite Kapurniotu - Germany
Efstathios Kastritis - Greece
Jeffrey W. Kelly - USA
Hiroaki Kitaoka - Japan
Haruki Koike - Japan
Arnt Kristen - Germany
Shaji Kumar - USA
Francesca Lavatelli Italy
Ahmed Masri - USA
Ellen D. McPhail - USA
Paolo Milani - Italy
Peter Mollee - Australia
Eli Muchtar - USA
Tomoaki Murakami - Japan
Hironobu Naiki - Japan
Tahara Nobuhiro - Japan
Mario Nuvolone - Italy
Laura Obici - Italy
Giovanni Palladini - Italy
Federico Perfetto - Italy
Stefano Perlini - Italy
Maria M. Picken - USA
Violaine Plante-Bordeneuve - France
Stanley B. Prusiner - USA
Sheena E. Radford - UK
Marina Ramirez-Alvarado - USA
Chris Röcken - Germany
Julie L. Rosenthal - USA
Frederick L. Ruberg - USA
Maria M. Saraiva - Portugal
Elisabeth Sauer-Eriksson - Sweden
Dennis J. Selkoe - USA
Louise Serpell - UK
Prem Soman - USA
Mitsuharu Ueda - Japan
Márcia Waddington Cruz - Brazil
Jonathan S. Wall - USA
Ashutosh Wechalekar - UK
Gunilla T. Westermark - Sweden
Jonas Wixner - Sweden

Abstracting and indexing

Amyloid: The Journal of Protein Folding Disorders is indexed/tracked/covered by the following services:

BIOSIS Previews (Clarivate Analytics)
Current Contents - Life Sciences (Clarivate Analytics)
Current Awareness in Biological Sciences
Embase (Elsevier)
Index Medicus (NLM)
ISI Research Alert
Medline (NLM)
PubMed (NLM)
PubMed Central Selective Deposit Medicine & Health (NLM)
Science Citation Index (Clarivate Analytics)
Science Citation Index Expanded (Clarivate Analytics)
Scopus (Elsevier)

Open access

Amyloid is a hybrid open access journal that is part of our Open Select publishing program, giving you the option to publish open access. Publishing open access means that your article will be free to access online immediately on publication, increasing the visibility, readership, and impact of your research.

Why choose open access?

  1. Increase the discoverability and readership of your article
  2. Make an impact and reach new readers, not just those with easy access to a research library
  3. Freely share your work with anyone, anywhere
  4. Comply with funding mandates and meet the requirements of your institution, employer or funder
  5. Rigorous peer review for every open access article

Article Publishing Charges (APC)

If you choose to publish open access in this journal you may be asked to pay an Article Publishing Charge (APC). You may be able to publish your article at no cost to yourself or with a reduced APC if your institution or research funder has an open access agreement or membership with Taylor & Francis.

Use our APC finder to calculate your article publishing charge

Advertising information

Would you like to advertise in Amyloid?

Reach an engaged target audience and position your brand alongside authoritative peer-reviewed research by advertising in Amyloid.

Explore advertising solutions

Taylor & Francis make every effort to ensure the accuracy of all the information (the "Content") contained in our publications. However, Taylor & Francis, our agents (including the editor, any member of the editorial team or editorial board, and any guest editors), and our licensors, make no representations or warranties whatsoever as to the accuracy, completeness, or suitability for any purpose of the Content. Any opinions and views expressed in this publication are the opinions and views of the authors, and are not the views of or endorsed by Taylor & Francis. The accuracy of the Content should not be relied upon and should be independently verified with primary sources of information. Taylor & Francis shall not be liable for any losses, actions, claims, proceedings, demands, costs, expenses, damages, and other liabilities whatsoever or howsoever caused arising directly or indirectly in connection with, in relation to, or arising out of the use of the Content. Terms & Conditions of access and use can be found at http://www.tandfonline.com/page/terms-and-conditions .

Ready to submit?

Start a new submission or continue a submission in progress

Go to submission site (link opens in a new window) Instructions for authors